<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-11T00:26:02Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.32428" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.32428</identifier>
    <datestamp>2026-04-10T14:44:36Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-04-10</dc:date>
  <dc:title>Tannic Acid Targets Small Protein B to Regulate Biofilms and Ameliorate Multi‑Organ Injury in a Murine Model of Methicillin-resistant Staphylococcus aureus‑induced Sepsis</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.32428</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>Methicillin-resistant Staphylococcus aureus&amp;nbsp;(MRSA)-induced sepsis poses clinical challenges due to multidrug resistance. Tannic acid (TA), a natural polyphenol, is a potential antibacterial agent; however, its core anti-MRSA targets and molecular mechanisms remain unclear. Small protein B (SmpB), a key regulator of the bacterial trans-translation system, contributes to biofilm formation, virulence expression, and stress adaptation. Therefore, this study aimed to elucidate the mechanism through which TA targets SmpB for MRSA&amp;nbsp;inhibition. In vitro, TA significantly reduced MRSA biofilm biomass with an 81.65% inhibition rate at 1/2 minimum inhibitory concentration and disrupted its structural integrity. Through proteomics, protein&amp;ndash;protein interaction analysis and molecular docking with a binding free energy of -6.971 kcal&amp;middot;mol⁻&amp;sup1;, SmpB may have been the core target of TA. The MRSA USA300 deletion strain (&amp;Delta;smpB) showed significantly reduced biofilm formation, impaired structural integrity and decreased extracellular matrix synthesis, while the complemented strain restored these phenotypes&amp;nbsp;(p&amp;nbsp;&amp;lt; 0.01). In a murine sepsis model, tannic acid alleviated pathological injury in the lung, liver, and kidney, and downregulated the transcriptional and protein levels of inflammatory factors interleukin 1&amp;beta; and 6, tumor necrosis factor &amp;alpha; and procalcitonin. Mice infected with &amp;Delta;smpB&amp;nbsp;had milder organ damage and lower inflammation than wild-type-infected mice, and TA treatment in &amp;Delta;smpB-infected mice achieved superior therapeutic effects. This study demonstrated that TA exerts anti-MRSA activity through modulating SmpB to inhibit biofilm formation and elucidated its mechanism of action.</dc:description>
  <dc:subject>Tannic acid; MRSA; SmpB protein; Biofilm; Sepsis</dc:subject>
  <dc:creator>Zhongxu Wu</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/publicdomain/zero/1.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>